224 related articles for article (PubMed ID: 18931326)
1. Immunostimulation with macrophage-activating lipopeptide-2 increased survival in murine pneumonia.
Reppe K; Tschernig T; Lührmann A; van Laak V; Grote K; Zemlin MV; Gutbier B; Müller HC; Kursar M; Schütte H; Rosseau S; Pabst R; Suttorp N; Witzenrath M
Am J Respir Cell Mol Biol; 2009 Apr; 40(4):474-81. PubMed ID: 18931326
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary immunostimulation with MALP-2 in influenza virus-infected mice increases survival after pneumococcal superinfection.
Reppe K; Radünzel P; Dietert K; Tschernig T; Wolff T; Hammerschmidt S; Gruber AD; Suttorp N; Witzenrath M
Infect Immun; 2015 Dec; 83(12):4617-29. PubMed ID: 26371127
[TBL] [Abstract][Full Text] [Related]
3. Local pulmonary immune stimulation by the Toll-like receptor 2 and 6 ligand MALP-2 in rats is age dependent.
Lührmann A; Grote K; Stephan M; Tschernig T; Pabst R
Immunol Lett; 2007 Feb; 108(2):167-73. PubMed ID: 17275100
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of TLR-2/6 ligation in pulmonary bacterial infection and immunization with Pseudomonas aeruginosa.
Kerber-Momot T; Leemhuis D; Lührmann A; Munder A; Tümmler B; Pabst R; Tschernig T
Inflammation; 2010 Feb; 33(1):58-64. PubMed ID: 19844782
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the inflammatory response to Streptococcus pneumoniae in a model of acute lung tissue infection.
Xu F; Droemann D; Rupp J; Shen H; Wu X; Goldmann T; Hippenstiel S; Zabel P; Dalhoff K
Am J Respir Cell Mol Biol; 2008 Nov; 39(5):522-9. PubMed ID: 18483419
[TBL] [Abstract][Full Text] [Related]
6.
Bradshaw JL; Caballero AR; Bierdeman MA; Adams KV; Pipkins HR; Tang A; O'Callaghan RJ; McDaniel LS
mSphere; 2018; 3(3):. PubMed ID: 29720526
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of pulmonary immune responses by the TLR2/6 agonist MALP-2 and effect on melanoma metastasis to the lung.
Schill T; Schön MP; Pletz N; Emmert S; Schön M
Exp Dermatol; 2012 Feb; 21(2):91-8. PubMed ID: 22044500
[TBL] [Abstract][Full Text] [Related]
8. In vivo effects of a synthetic 2-kilodalton macrophage-activating lipopeptide of Mycoplasma fermentans after pulmonary application.
Lührmann A; Deiters U; Skokowa J; Hanke M; Gessner JE; Mühlradt PF; Pabst R; Tschernig T
Infect Immun; 2002 Jul; 70(7):3785-92. PubMed ID: 12065522
[TBL] [Abstract][Full Text] [Related]
9. Decreased alveolar macrophage apoptosis is associated with increased pulmonary inflammation in a murine model of pneumococcal pneumonia.
Marriott HM; Hellewell PG; Cross SS; Ince PG; Whyte MK; Dockrell DH
J Immunol; 2006 Nov; 177(9):6480-8. PubMed ID: 17056580
[TBL] [Abstract][Full Text] [Related]
10. Leptin corrects host defense defects after acute starvation in murine pneumococcal pneumonia.
Mancuso P; Huffnagle GB; Olszewski MA; Phipps J; Peters-Golden M
Am J Respir Crit Care Med; 2006 Jan; 173(2):212-8. PubMed ID: 16210671
[TBL] [Abstract][Full Text] [Related]
11. Influence of neutropenia on the course of serotype 8 pneumococcal pneumonia in mice.
Marks M; Burns T; Abadi M; Seyoum B; Thornton J; Tuomanen E; Pirofski LA
Infect Immun; 2007 Apr; 75(4):1586-97. PubMed ID: 17296760
[TBL] [Abstract][Full Text] [Related]
12. Leptin improves pulmonary bacterial clearance and survival in ob/ob mice during pneumococcal pneumonia.
Hsu A; Aronoff DM; Phipps J; Goel D; Mancuso P
Clin Exp Immunol; 2007 Nov; 150(2):332-9. PubMed ID: 17822444
[TBL] [Abstract][Full Text] [Related]
13. Krueppel-Like Factor 4 Expression in Phagocytes Regulates Early Inflammatory Response and Disease Severity in Pneumococcal Pneumonia.
Herta T; Bhattacharyya A; Rosolowski M; Conrad C; Gurtner C; Gruber AD; Ahnert P; Gutbier B; Frey D; Suttorp N; Hippenstiel S; Zahlten J
Front Immunol; 2021; 12():726135. PubMed ID: 34589087
[TBL] [Abstract][Full Text] [Related]
14. Recruitment of lymphocytes and dendritic cells from the blood to the bronchoalveolar space and the draining lymph nodes after a single intrabronchial application of the lipopeptide MALP-2.
Tschernig T; Lührmann A; Pabst R
Pathobiology; 2002-2003; 70(5):260-5. PubMed ID: 12771506
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor 2 plays a role in the early inflammatory response to murine pneumococcal pneumonia but does not contribute to antibacterial defense.
Knapp S; Wieland CW; van 't Veer C; Takeuchi O; Akira S; Florquin S; van der Poll T
J Immunol; 2004 Mar; 172(5):3132-8. PubMed ID: 14978119
[TBL] [Abstract][Full Text] [Related]
16. The scavenger receptor MARCO is required for lung defense against pneumococcal pneumonia and inhaled particles.
Arredouani M; Yang Z; Ning Y; Qin G; Soininen R; Tryggvason K; Kobzik L
J Exp Med; 2004 Jul; 200(2):267-72. PubMed ID: 15263032
[TBL] [Abstract][Full Text] [Related]
17. Prevotella intermedia induces severe bacteremic pneumococcal pneumonia in mice with upregulated platelet-activating factor receptor expression.
Nagaoka K; Yanagihara K; Morinaga Y; Nakamura S; Harada T; Hasegawa H; Izumikawa K; Ishimatsu Y; Kakeya H; Nishimura M; Kohno S
Infect Immun; 2014 Feb; 82(2):587-93. PubMed ID: 24478074
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid-Augmented Efferocytosis Inhibits Pulmonary Pneumococcal Clearance in Mice by Reducing Alveolar Macrophage Bactericidal Function.
Stolberg VR; McCubbrey AL; Freeman CM; Brown JP; Crudgington SW; Taitano SH; Saxton BL; Mancuso P; Curtis JL
J Immunol; 2015 Jul; 195(1):174-84. PubMed ID: 25987742
[TBL] [Abstract][Full Text] [Related]
19. IL-18 improves the early antimicrobial host response to pneumococcal pneumonia.
Lauw FN; Branger J; Florquin S; Speelman P; van Deventer SJ; Akira S; van der Poll T
J Immunol; 2002 Jan; 168(1):372-8. PubMed ID: 11751983
[TBL] [Abstract][Full Text] [Related]
20.
Yamaguchi M; Hirose Y; Takemura M; Ono M; Sumitomo T; Nakata M; Terao Y; Kawabata S
Front Cell Infect Microbiol; 2019; 9():301. PubMed ID: 31482074
[No Abstract] [Full Text] [Related]
[Next] [New Search]
